cd38 inhibitor benefits with 5-amino-1mq CD38-Induced Metabolic Dysfunction Primes Multiple Myeloma Cells for NAD+-Lowering Agents Peptides 5-Amino-1MQ (10 mg Vial)

cd38 inhibitor benefits with 5-amino-1mq CD38-Induced Metabolic Dysfunction Primes Multiple Myeloma Cells for NAD+-Lowering Agents Peptides 5-Amino-1MQ (10 mg Vial)

5-Amino-1MQ (10 mg Vial) Dosage Chart - Dosage Peptide

No typical human dose has been established

Peptides

Study records: Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high fat diet-induced obesity in mice., Nicotinamide N-methyltransferase inhibition mitigates obesity-related metabolic dysfunction., Development & validation of LC-MS/MS assay for 5-amino-1-methyl quinolinium in rat plasma: Application to pharmacokinetic and oral bioavailability studies., Nicotinamide N-methyltransferase inhibition mimics and boosts exercise-mediated improvements in muscle function in aged mice